The Spectrum of Kidney Involvement in Lymphoma: a Case Report and Review of the Literature

di Cohen, Lisa J, Rennke, Helmut G, Laubach, Jacob P, Humphreys, Benjamin D
Pubblicazione 2010

Kidney Disease and Multiple Myeloma

di Heher, Eliot C., Rennke, Helmut G., Laubach, Jacob P., Richardson, Paul G.
Pubblicazione 2013

Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3-Kinase pathway activation

di Laubach, Jacob P., Fu, Ping, Jiang, Xiaohong, Salter, Kelly H., Potti, Anil, Arcasoy, Murat O.
Pubblicazione 2009

Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia

di LAUBACH, JACOB P., MITSIADES, CONSTANTINE S., ROCCARO, ALDO M., GHOBRIAL, IRENE M., ANDERSON, KENNETH C., RICHARDSON, PAUL G.
Pubblicazione 2009

The challenge of cross-trial comparisons using limited data

di Laubach, Jacob P., Faber, Edward A., Voorhees, Peter, Moslehi, Javid, Varga, Cindy, Niculescu, Liviu, Anderson, Kenneth C., Richardson, Paul G.
Pubblicazione 2014

New developments in the management of relapsed/refractory multiple myeloma – the role of ixazomib

di Richardson, Paul G, Kumar, Shaji, Laubach, Jacob P, Paba-Prada, Claudia, Gupta, Neeraj, Berg, Deborah, van de Velde, Helgi, Moreau, Philippe
Pubblicato in J Blood Med (2017)

Bortezomib in the management of multiple myeloma

di Laubach, Jacob P, Mitsiades, Constantine S, Hideshima, Teru, Schlossman, Robert, Chauhan, Dharminder, Munshi, Nikhil, Ghobrial, Irene, Carreau, Nicole, Anderson, Kenneth C, Richardson, Paul G
Pubblicazione 2009

Pathological crystallization of human immunoglobulins

di Wang, Ying, Lomakin, Aleksey, Hideshima, Teru, Laubach, Jacob P., Ogun, Olutayo, Richardson, Paul G., Munshi, Nikhil C., Anderson, Kenneth C., Benedek, George B.
Pubblicazione 2012

Emerging treatments of multiple myeloma; beyond IMIDs and bortezomib

di Mitsiades, Constantine S., Hideshima, Teru, Chauhan, Dharminder, McMillin, Douglas W., Klippel, Steffen, Laubach, Jacob P., Munshi, Nikhil C., Anderson, Kenneth C., Richardson, Paul G.
Pubblicazione 2009

Phase transitions in human IgG solutions

di Wang, Ying, Lomakin, Aleksey, Latypov, Ramil F., Laubach, Jacob P., Hideshima, Teru, Richardson, Paul G., Munshi, Nikhil C., Anderson, Kenneth C., Benedek, George B.
Pubblicazione 2013

The Medical Research Council Myeloma IX trial: the impact on treatment paradigms*

di Richardson, Paul G, Laubach, Jacob P, Schlossman, Robert L, Ghobrial, Irene M, Mitsiades, Constantine S, Rosenblatt, Jacalyn, Mahindra, Anuj, Raje, Noopur, Munshi, Nikhil, Anderson, Kenneth C
Pubblicazione 2012

Phase 1 open-label study of panobinostat, lenalidomide, bortezomib + dexamethasone in relapsed and relapsed/refractory multiple myeloma

di Laubach, Jacob P., Tuchman, Sascha A., Rosenblatt, Jacalyn M., Mitsiades, Constantine S., Colson, Kathleen, Masone, Kelly, Warren, Diane, Redd, Robert A., Grayson, Dena, Richardson, Paul G.
Pubblicato in Blood Cancer J (2021)

Interpreting clinical trial data in multiple myeloma: translating findings to the real-world setting

di Richardson, Paul G., San Miguel, Jesus F., Moreau, Philippe, Hajek, Roman, Dimopoulos, Meletios A., Laubach, Jacob P., Palumbo, Antonio, Luptakova, Katarina, Romanus, Dorothy, Skacel, Tomas, Kumar, Shaji K., Anderson, Kenneth C.
Pubblicato in Blood Cancer J (2018)

Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis

di Alexander, Kevin M., Orav, John, Singh, Avinainder, Jacob, Sophia A., Menon, Adil, Padera, Robert F., Kijewski, Marie F., Liao, Ronglih, Di Carli, Marcelo F., Laubach, Jacob P., Falk, Rodney H., Dorbala, Sharmila
Pubblicato in JAMA Cardiol (2018)

Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1

di Richardson, Paul G., Zimmerman, Todd M., Hofmeister, Craig C., Talpaz, Moshe, Chanan-Khan, Asher A., Kaufman, Jonathan L., Laubach, Jacob P., Chauhan, Dharminder, Jakubowiak, Andrzej J., Reich, Steven, Trikha, Mohit, Anderson, Kenneth C.
Pubblicato in Blood (2016)

Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients

di Richardson, Paul G., Baz, Rachid, Wang, Michael, Jakubowiak, Andrzej J., Laubach, Jacob P., Harvey, R. Donald, Talpaz, Moshe, Berg, Deborah, Liu, Guohui, Yu, Jiang, Gupta, Neeraj, Di Bacco, Alessandra, Hui, Ai-Min, Lonial, Sagar
Pubblicato in Blood (2014)

Association between response kinetics and outcomes in relapsed/refractory multiple myeloma: analysis from TOURMALINE-MM1

di Garderet, Laurent, Laubach, Jacob P., Stoppa, Anne-Marie, Hari, Parameswaran, Cavo, Michele, Ludwig, Heinz, Mateos, María-Victoria, Luptakova, Katarina, Lin, Jianchang, Yung, Godwin, van de Velde, Helgi, Berg, Deborah, Moreau, Philippe, Richardson, Paul G.
Pubblicato in Leukemia (2018)

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

di Kumar, Shaji K., Berdeja, Jesus G., Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P., Hamadani, Mehdi, Stewart, A. Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L., Berg, Deborah, Liao, Eileen, Rajkumar, S. Vincent, Richardson, Paul G.
Pubblicato in Leukemia (2019)

Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenström Macroglobulinemia

di Treon, Steven P., Meid, Kirsten, Gustine, Joshua, Yang, Guang, Xu, Lian, Liu, Xia, Patterson, Christopher J., Hunter, Zachary R., Branagan, Andrew R., Laubach, Jacob P., Ghobrial, Irene M., Palomba, M. Lia, Advani, Ranjana, Castillo, Jorge J.
Pubblicato in J Clin Oncol (2021)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

di Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laubach, Jacob P., Stockerl‐Goldstein, Keith E., Kwei, Long, Clow, Fong, Elias, Laurence, Salman, Zeena, Graef, Thorsten, Bilotti, Elizabeth, Vij, Ravi
Pubblicato in Br J Haematol (2018)